FDA Sets New Hearing Date for Over-The-Counter Birth Control
Advocates for Youth welcomes the news that the FDA has rescheduled an advisory committee meeting to review HRA Pharma’s application to switch Opill, a progestin-only, daily birth control pill from prescription to over-the-counter status. The new dates - on May 9th and 10th - coincide with the 63rd anniversary of approval of the daily birth control pill, celebrated by advocates as #FreeThePill Day.